当前位置: 首页 > 期刊 > 《中医药临床杂志》 > 2012年第3期
编号:12211275
药物三联治疗慢性前列腺炎的临床观察
http://www.100md.com 2012年2月1日 《中国中医药咨讯》 2012年第3期
     【摘要】 目的:探讨舍尼通等药物联合治疗慢性前列腺炎的临床效果。方法:选择慢性前列腺炎患者52例,给予舍尼通,左氧氟沙星,萘哌地尔三联药物治疗。治疗后按国际慢性前列腺炎症状评分(NIH-CPSI)总分变化和前列腺按摩液(EPS)指标变化评估。结果:治疗后3周和6周,CPSI评分分别比治疗前平均降低6.5(26.4%)和11.8(47.9%),EPS中WBC计数分别比较治疗前平均降低9.7个/HP(39.9%)和14.7个/HP(60.5%.)。总有效率84.6%。结论:舍尼通等三联药物治疗可明显改善慢性前列腺炎患者的不适症状,前列腺液中的WBC计数明显降低,治疗效果良好。

    【关键词】 慢性前列腺炎;药物;临床观察Clinical survey of three-drugs consecutive therapy of chronic prostatititis

    【Abstract】 Objective To study the curative effect of consecutive three drugs on chronic prostatitis. Methods 52 cases of chronic prostatitis were treated with consecutive drugs with prostal,levoflxac in and naftopidil.After treatment,the curative effect was eveluated according to the NIH-CPSI and EPS exam inations. Results :After 3-and 6-week therapy . CPSI overall scores were averagely decreased 6.5 (26.4) and 11.8(47.9),respectively.WBC counts in EPS were averagely decreased 9.7/HP(39.9%) and 14.7/HP(60.5%),respectively.The total effectieve rate was 84.6% after 6 weeks,therapy. Conclusion Usage of three consecutive drugs in the treatment of chronic prostatitis patients are effective for relieving the symptoms and decreasing WBC counts in EPS. ......

您现在查看是摘要页,全文长 5166 字符